The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-(3-((2-Phenylquinolin-4-yl)amino)phenyl)acetamide ID: ALA4437626
PubChem CID: 155512695
Max Phase: Preclinical
Molecular Formula: C23H19N3O
Molecular Weight: 353.43
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: CC(=O)Nc1cccc(Nc2cc(-c3ccccc3)nc3ccccc23)c1
Standard InChI: InChI=1S/C23H19N3O/c1-16(27)24-18-10-7-11-19(14-18)25-23-15-22(17-8-3-2-4-9-17)26-21-13-6-5-12-20(21)23/h2-15H,1H3,(H,24,27)(H,25,26)
Standard InChI Key: MNCWMFWUVKUNLT-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
33.9615 -20.4297 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.9604 -21.2493 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6684 -21.6582 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.6667 -20.0209 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3753 -20.4261 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.3760 -21.2452 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0846 -21.6522 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7928 -21.2414 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7881 -20.4193 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0790 -20.0159 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.0747 -19.1987 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.7802 -18.7864 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4855 -19.1946 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1905 -18.7829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.1866 -17.9649 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4718 -17.5602 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.7697 -17.9742 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.4986 -21.6432 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.5004 -22.4615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2089 -22.8672 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9160 -22.4558 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9101 -21.6344 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.2011 -21.2324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
38.9002 -19.1881 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
39.6059 -18.7761 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.3156 -19.1813 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.6020 -17.9589 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
11 12 1 0
12 13 2 0
13 14 1 0
14 15 2 0
15 16 1 0
16 17 2 0
17 12 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
8 18 1 0
14 24 1 0
24 25 1 0
25 26 1 0
25 27 2 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 353.43Molecular Weight (Monoisotopic): 353.1528AlogP: 5.60#Rotatable Bonds: 4Polar Surface Area: 54.02Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 2#RO5 Violations (Lipinski): 1CX Acidic pKa: ┄CX Basic pKa: 6.67CX LogP: 4.84CX LogD: 4.77Aromatic Rings: 4Heavy Atoms: 27QED Weighted: 0.50Np Likeness Score: -1.16
References 1. Krapf MK, Wiese M.. (2016) Synthesis and Biological Evaluation of 4-Anilino-quinazolines and -quinolines as Inhibitors of Breast Cancer Resistance Protein (ABCG2)., 59 (11): [PMID:27148793 ] [10.1021/acs.jmedchem.6b00330 ]